Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Mackin ST, Nelson SM, Kerssens JJ, Wood R, Wild S, Colhoun HM, et al
Viking Therapeutics Headquarters: U.S.A Technology: GLP-1 and GIP receptor agonists Lead candidate: VK2735 California-based Viking Therapeutics weight loss drug is not only an agonist of GLP-1 but also of GIP receptors
In the short-term, demand may be somewhat curbed by governments and insurers being slow to reimburse, high out-of-pocket costs, supply shortages and side effect fears
Meet the Experts Marie Spano, RD is a sports nutritionist for Major League Baseball
US$ 23.13
US$ 25.04
US$ 20.43
